IPF event on Thursday 12 December,2024 hosted by Dr Mohan Kaul and moderated by Udayan Guha, delved into the complexities and opportunities within healthcare systems,
Dr Mohan Kaul highlighted the three Focus areas for IPF activities in the healthcare sector including mobilizing private investment, promoting digital innovation and education collaboration in the UK India Healthcare corridor. The discussion brought together a distinguished panel of experts, including Sir Malcolm Grant, Raghav Singhal, Professor Paul Edwards, Jonathan Lawrence, and Madhukar Bose.
The NHS: Challenges and Structural Evolution
Sir Malcolm Grant, founding chair of NHS England, reflected on the challenges and outcomes of the NHS reforms initiated by Andrew Lansley in 2011, which restructured the commissioning side of the NHS while leaving the delivery side largely unchanged. Originally named the NHS National Commissioning Board, the organisation was later rebranded NHS England to clarify its role. The reforms aimed to decentralise commissioning by replacing Primary Care Trusts and Strategic Health Authorities with 255 Clinical Commissioning Groups (CCGs), empowering GPs to oversee the commissioning of secondary, tertiary, and quaternary care.
Despite significant effort, the ambitious vision faced hurdles, including governance issues like conflicts of interest and the practical difficulties of establishing the CCGs as fully functional entities. The reforms, rooted in the white paper Liberating the NHS, sought to reduce political interference by having the government define strategy through an annual mandate and budget while NHS England focused on execution. However, the government’s strategy often undermined this separation, leading NHS England, under Sir Malcolm and Simon Stevens, to take a proactive role in defining long-term objectives, such as the Five-Year Forward View.
Sir Malcolm highlighted the persistent tensions in healthcare systems—between payers and users, national and local authorities, and clinical and non-clinical communities—arguing that healthcare structures inevitably settle into temporary equilibria rather than lasting solutions. Nevertheless, he noted that frontline medical professionals largely continued their work unaffected, underscoring that patient care must remain insulated from bureaucratic disruption.
India's Role in Global Healthcare
Raghav, UK CEO of ICICI Bank, highlighted India's growing significance in the global healthcare market. As the fifth-largest economy with a thriving pharmaceutical industry, India offers world-class healthcare facilities at a fraction of the cost compared to the UK. He cited examples of advanced diagnostic capabilities in India, where blood test results are available within hours and high-end medical services are accessible to many.
ICICI Bank, though not a healthcare provider, acts as an enabler by facilitating financial and mobility solutions. The bank's platforms allow seamless cross-border financial transactions, including setting up NHS accounts remotely, thereby easing the lives of Indian diaspora in the UK. Raghav stressed the importance of collaboration, urging stakeholders to ask how they can contribute to a shared vision of accessible, world-class healthcare.
Workforce Shortages and Patient Flow
Professor Paul Edwards from Aneurin Bevan University emphasized the critical workforce challenges, especially within Wales, where 31% of doctors are international medical graduates, many from India. He outlined upcoming projects aimed at recruiting Indian healthcare professionals to address workforce shortages, improve patient flow, and reduce waiting times. Such initiatives not only alleviate immediate staffing challenges but also create educational opportunities for Indian doctors in the UK.
Opportunities Amid NHS Strains
Jonathan Lawrence, a healthcare entrepreneur, shared his dual perspectives from working in both public and private healthcare. He identified workforce shortages, inefficient patient flow, and the strain on elective care as persistent issues. The current NHS waiting list of 7.6 million underscores the urgency of integrating health and social care and increasing patient throughput by at least 20% to reverse the backlog.
Jonathan noted the rise of private healthcare as an alternative for patients seeking faster, lower-complexity procedures. A generational shift is emerging, with younger patients turning to private options to avoid prolonged NHS waiting times. This shift creates commercial opportunities for private healthcare providers and investors, particularly for scalable, cost-effective solutions.
Digital Health and Cross-Border Collaboration
Madhukar Bose from the Department for Business and Trade (DBT) highlighted the transformative potential of digital health and the role of UK-India collaboration. The DBT supports British digital health companies in scaling up globally, with initiatives like the UK’s Digital Health Playbook and accelerator programs in markets such as the US and India.
Madhukar stressed the importance of leveraging data as a strategic asset. Recent advancements, such as the NHS's federated data platform, aim to consolidate data for better healthcare solutions. However, regulatory challenges around technology safety and compliance must be addressed. He advocated for combining India's technological innovation and clinical expertise with the UK’s research capabilities to create world-class healthcare solutions that can access global markets.
Following the panel discussion was a talk by Dr Abhay Chopada
Revolutionizing Healthcare with AI: Dr. Abhay Chapada’s Vision
Dr. Abhay Chopada delivered a transformative talk on how artificial intelligence (AI) is reshaping the future of healthcare. Showcasing his Axonic product, he provided a live demonstration of its AI-powered triage system, capable of translating languages and delivering personalised medical advice based on patient symptoms. Dr. Chopada highlighted the vision of AI-powered health solutions, including an empowered patient health passbook, a home health portal, and health ATMs for decentralised healthcare access. These innovations aim to bridge gaps in healthcare delivery, making it accessible, affordable, and efficient. Dr. Chopada emphasised the need for the industry to think differently, stating, “The question is, are we prepared to assume healthcare must always work the way it does today?”
Through Axonic, he explained how 36 specialty AI bots were developed in just 18 months, analysing 1.3 million medical reports. Validated across thousands of cases, these AI bots outperformed human accuracy rates, achieving 89% compared to a typical 84%. He stressed the urgency of adopting such technologies, citing the staggering human and financial costs of delayed care, inaccessible services, and fragmented data systems. Breaking down data silos and enabling seamless data sharing, he argued, could save billions annually and significantly reduce patient suffering.
He envisions a world where a personal AI doctor, accessible 24/7, captures patient data in real-time, ensuring prompt, precise care. Dr. Chapada’s compelling insights left the audience envisioning a future where AI revolutionizes healthcare delivery, democratising access and improving outcomes on a global scale.
To Conclude
The panel discussion illuminated the pressing challenges and emerging opportunities within the global healthcare ecosystem, from workforce shortages and inefficient systems to the transformative role of digital health and AI. Insights from leaders across public and private sectors emphasised collaboration, innovation, and breaking traditional silos to drive efficiency and accessibility.
AI in healthcare exemplifies the potential for technology to revolutionise patient care, making it personalised, affordable, and universally accessible. As healthcare evolves, these discussions highlight a critical call to action: harness collective expertise and technology to build a more equitable and efficient system for the future.
Comments